Literature DB >> 3998764

Induction by interferon-alpha of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cells.

S Sone, T Utsugi, T Shirahama, K Ishii, S Mutsuura, M Ogawara.   

Abstract

Human blood monocytes, separated on a Percoll gradient, were not cytotoxic to allogeneic melanoma (A375) cells. Fluorescent analysis showed that the monocytes were contaminated with up to 2.0% natural killer (NK) cells. The monocytes became tumoricidal on incubation for 24 h with greater than or equal to 1,000 IU/ml interferon-alpha (IFN-alpha) derived from human lymphoblastic leukemia cells. Anti-IFN-alpha antibody abolished the ability of IFN-alpha to render the monocytes tumoricidal, whereas anti-IFN-beta antibody had no effect. Pretreatment of isolated monocyte preparations with anti-NK cell monoclonal antibodies (Leu-7 and Leu-11b), to inhibit NK cell activity, did not affect the cytotoxicity of IFN-alpha-activated monocytes on tumor cells. Full expression of cytotoxicity on tumor cells required the interaction of monocytes with IFN-alpha for 24 h. These results indicate that IFN-alpha directly activates human monocytes to become tumoricidal, although greater than or equal to 1,000 IU/ml IFN-alpha is required for maximal activation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3998764

Source DB:  PubMed          Journal:  J Biol Response Mod        ISSN: 0732-6580


  2 in total

1.  Synergism of synthetic acyltripeptide and its analogs with recombinant interferon gamma for activation of antitumor properties of human blood monocytes.

Authors:  S Sone; A Okubo; N Inamura; A Nii; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

2.  Monoclonal anti-P-glycoprotein antibody-dependent killing of multidrug-resistant tumor cells by human mononuclear cells.

Authors:  Y Heike; H Hamada; N Inamura; S Sone; T Ogura; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1990-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.